Summary
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening
CapsoVision NASDAQ: CV outlined its strategy to expand capsule endoscopy technology beyond its current small-bowel business into colon, pancreatic and esophageal cancer screening applications, highlighting its artificial intelligence capabilities, cloud-based workflow and upcoming regulatory submissions.
CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript
CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript
CapsoVision Q2 Earnings Call Highlights
CapsoVision NASDAQ: CV reported second-quarter revenue growth as sales of its CapsoCam Plus capsule endoscopy system increased, while the company advanced its artificial intelligence software rollout and development programs for colon and upper gastrointestinal applications.
CapsoVision, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 4 | $33.5 | $27.52 | -$5.98 | -17.85% |
| CD Charlie Durham Sterling Capital Management LLC | 1,144 | $7,491.31 | $7,992.44 | $501.13 | 6.69% |
 Joseph Castro Nuveen LLC | 46,011 | $339,164.43 | $319,339.35 | -$19,825.08 | -5.85% |
 Drew Phillips Fortitude Family Office LLC | 83 | $536 | $571.87 | $35.87 | 6.69% |
 Alexandra Stickelman Root Financial Partners, LLC | 47 | $304 | $319.6 | $15.6 | 5.13% |
CapsoVision, Inc. (CV) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has CapsoVision, Inc. ever had a stock split?
CapsoVision, Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Kang-Huai Wang CEO | NASDAQ (CM) Exchange | 140935107 CUSIP |
| US Country | 99 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
The company is a leader in the medical technology sector, specializing in the development of innovative solutions for gastrointestinal diagnostics. Their commitment to advancing healthcare is evident through their cutting-edge products, such as the CapsoCam Plus and CapsoCam Colon systems, which utilize capsule endoscopy. These technologies enhance the precision and effectiveness of gastrointestinal examinations and empower healthcare professionals with more reliable data. Additionally, the integration of artificial intelligence in their imaging platforms signifies a forward-thinking approach, aiming to improve the diagnostic process and overall patient care. By leveraging advanced technology and continuous research, the company strives to redefine standards in the medical diagnostics industry.
Products and Services
- CapsoCam Plus:
This advanced capsule endoscopy system offers a comprehensive solution for visualizing the small intestine. With its 360-degree imaging capabilities, the CapsoCam Plus allows for detailed examination and facilitates early detection of gastrointestinal diseases.
- CapsoCam Colon:
Designed specifically for colon examination, CapsoCam Colon combines ease of use with high-resolution imaging. This system helps clinicians to achieve thorough assessments of the colon, enhancing the overall diagnostic accuracy for conditions such as polyps and colorectal cancer.
- AI-Enabled Imaging Platforms:
These platforms are equipped with artificial intelligence capabilities that assist in the interpretation of images captured during endoscopic procedures. The AI technology enhances diagnostic precision, aids in identifying abnormalities, and supports clinicians in making informed decisions regarding patient care.
Contact Information
